TELA
Tela Bio Inc
NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES
$0.87
+1.72% today
Updated 2026-04-30
Market cap
$34.90M
P/E ratio
—
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Tela Bio Inc (TELA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-48.40%
Operating margin
-31.90%
ROE
-223.30%
ROA
-25.10%
Debt/equity
26.98x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $4.25M | $-21.33M | 59.65% | -398.68% | -502.57% |
| 2018 | $8.27M | $-21.09M | 35.56% | -214.91% | -254.92% |
| 2019 | $15.45M | $-22.43M | 60.03% | -124.06% | -145.18% |
| 2020 | $18.21M | $-28.79M | 61.68% | -138.77% | -158.10% |
| 2021 | $29.46M | $-33.28M | 63.85% | -99.96% | -112.94% |
| 2022 | $41.42M | $-44.30M | 65.30% | -94.18% | -106.95% |
| 2023 | $58.45M | $-46.66M | 68.62% | -75.40% | -79.83% |
| 2024 | $69.30M | $-37.84M | 67.08% | -49.23% | -54.60% |
| 2025 | $80.28M | $-38.83M | 67.69% | -42.05% | -48.37% |